APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage-Reference-Cited by-同舟云学术

APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage

Published:2024-09-12 Issue:1 Volume:11 Page:
ISSN:2045-0923
Container-title:Hepatic Oncology
language:en
Short-container-title:Hepatic Oncology

Author:

Wang Xiaojing¹,Ishimatsu Keisuke¹,Li Junjie¹,Wen Xiaodong¹,Ou Weijun¹²,Anwar Arnida¹,Chaudhary Jaideep¹,Takahashi Masaya¹,Sherry A Dean¹³,Corbin Ian R¹³⁴^ORCID

Affiliation:

1. Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA

2. Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China

3. Internal Medicine Division of Liver & Digestive Diseases, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA

4. Department of Radiology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA

Funder

National Cancer Institute

Remeditex Ventures LCC

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20450923.2024.2389031

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

3. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass

4. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review

5. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma